Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Julia J. Bradford"'
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
Treatment for metastatic melanoma includes targeted and/or immunotherapy. Although many patients respond, only a subset has complete response. As late-stage patients often have multiple tumors in difficult access sites, non-invasive techniques are ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f97b1240044fb8b2cbde3e678fa16bff
https://doi.org/10.1158/1541-7786.c.6545076.v1
https://doi.org/10.1158/1541-7786.c.6545076.v1
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
Kaplan-Meier (log-rank) analysis of MPP4 and SD3 showing the PFS and OS for stage III patients only. a. PFS for MPP4, **p=0.0017, b. OS for MPP4, *p=0.0117, c. PFS for SD3, ***p=0.0003 and d. OS for SD3, **p=0.0094.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f040cccdef8feb541b68139b6f71b5
https://doi.org/10.1158/1541-7786.22526397
https://doi.org/10.1158/1541-7786.22526397
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
Multiplex immunofluorescence staining quantification by Visiopharm Image Analytical System. DAPI nuclei were segmented defining the areas. Then each marker was quantified within this DAPI area. MPP4 low (MelR062) and MPP4 high (MelR166) phenotypes ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7146eeafe20b948699b45e4ce745c2ec
https://doi.org/10.1158/1541-7786.22526391.v1
https://doi.org/10.1158/1541-7786.22526391.v1
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
Table S1. Patient Characteristics. AJCC: American Joint Committee on Cancer Table S2. Clinical information including histology, stage and survival. Table S3. Univariate analysis of clinico-pathological and CT features. Log-rank (Mantel-Cox) test to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e238e944f47b1f9a7e90210ae6a21a80
https://doi.org/10.1158/1541-7786.22526388.v1
https://doi.org/10.1158/1541-7786.22526388.v1
Autor:
Andrew P. Barbour, Kenneth Miles, Nicola Waddell, B. Mark Smithers, Samuel Yang, Gerard Bayley, Geoffrey Strutton, Phillip Law, Victoria Atkinson, Conor J. Bloxham, Julia J. Bradford, Kalpana Patel, Harald Oey, John V. Pearson, Marjan M. Naeini, Lambros T. Koufariotis, Shaun B. Walters, Sandra Brosda, Vanessa F. Bonazzi, Bernadette Z.Y. Wong, Lauren G. Aoude
The association between TMB and SD3/MPP4 is not statistically significant. A. MPP4, not significant, Fisher's exact. B. SD3, not significant, Fisher's exact.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c83c28f7b9da633dc18a4e63a7475fb
https://doi.org/10.1158/1541-7786.22526394.v1
https://doi.org/10.1158/1541-7786.22526394.v1
Autor:
Lambros T. Koufariotis, James M. Lonie, Vanessa F. Bonazzi, Sandra Brosda, Julia J. Bradford, B. Mark Smithers, Kalpana Patel, Nicola Waddell, Lauren G. Aoude, Andrew Barbour, Scott Wood
Background: The incidence of oesophageal adenocarcinoma (OAC) is rapidly increasing and despite improvements in treatment, the five-year survival rate remains poor. Prognostic biomarkers that address the genomic heterogeneity in this highly complex d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7519c1e65b7ba9a578e1b1cc74deffec
https://doi.org/10.21203/rs.3.rs-1041840/v1
https://doi.org/10.21203/rs.3.rs-1041840/v1
Autor:
Samuel Yang, Marjan Mojtabavi Naeini, Shaun B. Walters, Vanessa F. Bonazzi, Lambros T. Koufariotis, Harald Oey, Geoffrey Strutton, Andrew Barbour, Julia J. Bradford, Kenneth A. Miles, Lauren G. Aoude, Gerard Bayley, Kalpana Patel, Nicola Waddell, Sandra Brosda, Bernadette Z.Y. Wong, Victoria Atkinson, B. Mark Smithers, Phillip Law, John V. Pearson, Conor J. Bloxham
Publikováno v:
Molecular cancer research : MCR. 19(6)
Treatment for metastatic melanoma includes targeted and/or immunotherapy. Although many patients respond, only a subset has complete response. As late-stage patients often have multiple tumors in difficult access sites, non-invasive techniques are ne